Landec Corporation provided revenue guidance for the full year fiscal 2023. For the year, the company expects Lifecore segment revenue of range of $122 million to $126 million (+12% to +15%).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.35 USD | -1.40% | -4.37% | +2.58% |
04-19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
04-01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.58% | 194M | |
+29.68% | 681B | |
+19.83% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.32% | 235B | |
+4.37% | 199B | |
-11.78% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- LFCR Stock
- News Lifecore Biomedical, Inc.
- Landec Corporation Provides Revenue Guidance for the Full Year Fiscal 2023